{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:44:32Z","timestamp":1762508672929,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic kidney disorder. Half of the patients would slowly progress to end-stage renal disease. However, the potential target for ADPKD treatment is still lacking.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Four ADPKD patients and two healthy family members were included in this study. The peripheral blood samples were obtained and tested by the whole exome sequencing (WES). The autosomal mutations in ADPKD patients were retained as candidate sites. The Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, and protein\u2013protein interaction network (PPI) analyses were performed by clusterProfiler R package. A dataset containing 18 ADPKD patients and three normal samples were downloaded from the Gene Expression Omnibus (GEO) database and analyzed using the limma R package.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of six mutant genes were identified based on the dominant genetic pattern and most of them had not been reported to be associated with ADPKD. Furthermore, 19 harmful genes were selected according to the harmfulness of mutation. GO and KEGG enrichment analyses showed that the processes of single-organism cellular process, response to stimulus, plasma membrane, cell periphery, and anion binding as well as cyclic adenosine monophosphate (cAMP) signaling pathway and pathways in cancer were significantly enriched. Through integrating PPI and gene expression analyses, acyl-CoA thioesterase 13 (<jats:italic>ACOT13<\/jats:italic>), which has not been reported to be related to ADPKD, and prostaglandin E receptor 2 (<jats:italic>PTGER2<\/jats:italic>) were identified as potential genes associated with ADPKD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Through combination of WES, gene expression, and PPI network analyses, we identified <jats:italic>ACOT13<\/jats:italic> and <jats:italic>PTGER2<\/jats:italic> as potential ADPKD-related genes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-021-00613-8","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T11:11:23Z","timestamp":1639048283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification of ACOT13 and PTGER2 as novel candidate genes of autosomal dominant polycystic kidney disease through whole exome sequencing"],"prefix":"10.1186","volume":"26","author":[{"given":"Na","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihe","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6200-0936","authenticated-orcid":false,"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"issue":"1","key":"613_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","volume":"4","author":"C Bergmann","year":"2018","unstructured":"Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE. Polycystic kidney disease. Nat Rev Dis Primers. 2018;4(1):50. https:\/\/doi.org\/10.1038\/s41572-018-0047-y.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"613_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nsmb.3343","volume":"24","author":"M Grieben","year":"2017","unstructured":"Grieben M, Pike AC, Shintre CA, Venturi E, El-Ajouz S, Tessitore A, Shrestha L, Mukhopadhyay S, Mahajan P, Chalk R, et al. Structure of the polycystic kidney disease TRP channel Polycystin-2 (PC2). Nat Struct Mol Biol. 2017;24(2):114\u201322. https:\/\/doi.org\/10.1038\/nsmb.3343.","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"613_CR3","doi-asserted-by":"publisher","first-page":"F414","DOI":"10.1152\/ajprenal.00167.2018","volume":"316","author":"P Chumley","year":"2019","unstructured":"Chumley P, Zhou J, Mrug S, Chacko B, Parant JM, Challa AK, Wilson LS, Berryhill TF, Barnes S, Kesterson RA, et al. Truncating PKHD1 and PKD2 mutations alter energy metabolism. Am J Physiol Renal Physiol. 2019;316(3):F414\u201325. https:\/\/doi.org\/10.1152\/ajprenal.00167.2018.","journal-title":"Am J Physiol Renal Physiol"},{"key":"613_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-981-10-2041-4_2","volume":"933","author":"DY Kim","year":"2016","unstructured":"Kim DY, Park JH. Genetic mechanisms of ADPKD. Adv Exp Med Biol. 2016;933:13\u201322. https:\/\/doi.org\/10.1007\/978-981-10-2041-4_2.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"613_CR5","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","volume":"102","author":"GE Cornec-Le","year":"2018","unstructured":"Cornec-Le GE, Olson RJ, Besse W, Heyer CM, Gainullin VG, Smith JM, Audrezet MP, Hopp K, Porath B, Shi B, et al. Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease. Am J Hum Genet. 2018;102(5):832\u201344. https:\/\/doi.org\/10.1016\/j.ajhg.2018.03.013.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"613_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41581-018-0051-1","volume":"14","author":"V Padovano","year":"2018","unstructured":"Padovano V, Podrini C, Boletta A, Caplan MJ. Metabolism and mitochondria in polycystic kidney disease research and therapy. Nat Rev Nephrol. 2018;14(11):678\u201387. https:\/\/doi.org\/10.1038\/s41581-018-0051-1.","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"613_CR7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/14737159.2017.1386099","volume":"17","author":"C Bergmann","year":"2017","unstructured":"Bergmann C. Recent advances in the molecular diagnosis of polycystic kidney disease. Expert Rev Mol Diagn. 2017;17(12):1037\u201354. https:\/\/doi.org\/10.1080\/14737159.2017.1386099.","journal-title":"Expert Rev Mol Diagn"},{"issue":"18","key":"613_CR8","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1001\/jama.2014.14601","volume":"312","author":"Y Yang","year":"2014","unstructured":"Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, Ward P, Braxton A, Wang M, Buhay C, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312(18):1870\u20139. https:\/\/doi.org\/10.1001\/jama.2014.14601.","journal-title":"JAMA"},{"issue":"11","key":"613_CR9","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/ejhg.2016.48","volume":"24","author":"AC Mallawaarachchi","year":"2016","unstructured":"Mallawaarachchi AC, Hort Y, Cowley MJ, McCabe MJ, Minoche A, Dinger ME, Shine J, Furlong TJ. Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney disease. Eur J Hum Genet. 2016;24(11):1584\u201390. https:\/\/doi.org\/10.1038\/ejhg.2016.48.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"613_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/ki.2015.317","volume":"89","author":"DA Braun","year":"2016","unstructured":"Braun DA, Schueler M, Halbritter J, Gee HY, Porath JD, Lawson JA, Airik R, Shril S, Allen SJ, Stein D, et al. Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicity. Kidney Int. 2016;89(2):468\u201375. https:\/\/doi.org\/10.1038\/ki.2015.317.","journal-title":"Kidney Int"},{"issue":"17","key":"613_CR11","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884\u201390. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560.","journal-title":"Bioinformatics"},{"issue":"7","key":"613_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073\u201381. https:\/\/doi.org\/10.1038\/nprot.2009.86.","journal-title":"Nat Protoc"},{"issue":"4","key":"613_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/gtmb.2010.0036","volume":"14","author":"SE Flanagan","year":"2010","unstructured":"Flanagan SE, Patch AM, Ellard S. Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomarkers. 2010;14(4):533\u20137. https:\/\/doi.org\/10.1089\/gtmb.2010.0036.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"8","key":"613_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nmeth0810-575","volume":"7","author":"JM Schwarz","year":"2010","unstructured":"Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575\u20136. https:\/\/doi.org\/10.1038\/nmeth0810-575.","journal-title":"Nat Methods"},{"issue":"2","key":"613_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nmeth.3739","volume":"13","author":"Y Itan","year":"2016","unstructured":"Itan Y, Shang L, Boisson B, Ciancanelli MJ, Markle JG, Martinez-Barricarte R, Scott E, Shah I, Stenson PD, Gleeson J, et al. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat Methods. 2016;13(2):109\u201310. https:\/\/doi.org\/10.1038\/nmeth.3739.","journal-title":"Nat Methods"},{"issue":"3","key":"613_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/humu.22932","volume":"37","author":"X Liu","year":"2016","unstructured":"Liu X, Wu C, Li C, Boerwinkle E. dbNSFP v3.0: a one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs. Hum Mutat. 2016;37(3):235\u201341. https:\/\/doi.org\/10.1002\/humu.22932.","journal-title":"Hum Mutat"},{"issue":"5","key":"613_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"issue":"13","key":"613_CR18","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","volume":"18","author":"X Song","year":"2009","unstructured":"Song X, Di Giovanni V, He N, Wang K, Ingram A, Rosenblum ND, Pei Y. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet. 2009;18(13):2328\u201343. https:\/\/doi.org\/10.1093\/hmg\/ddp165.","journal-title":"Hum Mol Genet"},{"key":"613_CR19","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.9005.3","author":"CW Law","year":"2016","unstructured":"Law CW, Alhamdoosh M, Su S, Dong X, Tian L, Smyth GK, Ritchie ME. RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR. F1000Res. 2016. https:\/\/doi.org\/10.12688\/f1000research.9005.3.","journal-title":"F1000Res"},{"issue":"10174","key":"613_CR20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393(10174):919\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(18)32782-X.","journal-title":"Lancet"},{"issue":"7","key":"613_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41581-019-0143-6","volume":"15","author":"D Douguet","year":"2019","unstructured":"Douguet D, Patel A, Honore E. Structure and function of polycystins: insights into polycystic kidney disease. Nat Rev Nephrol. 2019;15(7):412\u201322. https:\/\/doi.org\/10.1038\/s41581-019-0143-6.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"613_CR22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/cphy.c160018","volume":"7","author":"J Ghata","year":"2017","unstructured":"Ghata J, Cowley BD Jr. Polycystic kidney disease. Compr Physiol. 2017;7(3):945\u201375. https:\/\/doi.org\/10.1002\/cphy.c160018.","journal-title":"Compr Physiol"},{"issue":"1\u20132","key":"613_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11010-018-3358-0","volume":"449","author":"W Shi","year":"2018","unstructured":"Shi W, Xu D, Gu J, Xue C, Yang B, Fu L, Song S, Liu D, Zhou W, Lv J, et al. Saikosaponin-d inhibits proliferation by up-regulating autophagy via the CaMKKbeta-AMPK-mTOR pathway in ADPKD cells. Mol Cell Biochem. 2018;449(1\u20132):219\u201326. https:\/\/doi.org\/10.1007\/s11010-018-3358-0.","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"613_CR24","doi-asserted-by":"publisher","first-page":"eaaw3593","DOI":"10.1126\/sciadv.aaw3593","volume":"5","author":"Y Sun","year":"2019","unstructured":"Sun Y, Liu Z, Cao X, Lu Y, Mi Z, He C, Liu J, Zheng Z, Li MJ, Li T, et al. Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease. Sci Adv. 2019;5(6):eaaw3593. https:\/\/doi.org\/10.1126\/sciadv.aaw3593.","journal-title":"Sci Adv"},{"issue":"46","key":"613_CR25","doi-asserted-by":"publisher","first-page":"33376","DOI":"10.1074\/jbc.M113.481408","volume":"288","author":"HW Kang","year":"2013","unstructured":"Kang HW, Ozdemir C, Kawano Y, LeClair KB, Vernochet C, Kahn CR, Hagen SJ, Cohen DE. Thioesterase superfamily member 2\/Acyl-CoA thioesterase 13 (Them2\/Acot13) regulates adaptive thermogenesis in mice. J Biol Chem. 2013;288(46):33376\u201386. https:\/\/doi.org\/10.1074\/jbc.M113.481408.","journal-title":"J Biol Chem"},{"issue":"1","key":"613_CR26","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1038\/s41598-018-20856-6","volume":"8","author":"CC Lin","year":"2018","unstructured":"Lin CC, Kurashige M, Liu Y, Terabayashi T, Ishimoto Y, Wang T, Choudhary V, Hobbs R, Liu LK, Lee PH, et al. A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed. Sci Rep. 2018;8(1):2743. https:\/\/doi.org\/10.1038\/s41598-018-20856-6.","journal-title":"Sci Rep"},{"issue":"6","key":"613_CR27","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/cncr.23694","volume":"113","author":"L Tian","year":"2008","unstructured":"Tian L, Suzuki M, Nakajima T, Kubo R, Sekine Y, Shibuya K, Hiroshima K, Nakatani Y, Fujisawa T, Yoshino I, et al. Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation. Cancer. 2008;113(6):1396\u2013403. https:\/\/doi.org\/10.1002\/cncr.23694.","journal-title":"Cancer"},{"issue":"3","key":"613_CR28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1158\/1055-9965.EPI-09-1154","volume":"19","author":"Y Baba","year":"2010","unstructured":"Baba Y, Nosho K, Shima K, Goessling W, Chan AT, Ng K, Chan JA, Giovannucci EL, Fuchs CS, Ogino S. PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. Cancer Epidemiol Biomarkers Prev. 2010;19(3):822\u201331. https:\/\/doi.org\/10.1158\/1055-9965.EPI-09-1154.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"53","key":"613_CR29","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1038\/sj.onc.1210550","volume":"26","author":"Y Sugino","year":"2007","unstructured":"Sugino Y, Misawa A, Inoue J, Kitagawa M, Hosoi H, Sugimoto T, Imoto I, Inazawa J. Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas. Oncogene. 2007;26(53):7401\u201313. https:\/\/doi.org\/10.1038\/sj.onc.1210550.","journal-title":"Oncogene"},{"issue":"10","key":"613_CR30","doi-asserted-by":"publisher","first-page":"F1425","DOI":"10.1152\/ajprenal.00010.2012","volume":"303","author":"Y Liu","year":"2012","unstructured":"Liu Y, Rajagopal M, Lee K, Battini L, Flores D, Gusella GL, Pao AC, Rohatgi R. Prostaglandin E(2) mediates proliferation and chloride secretion in ADPKD cystic renal epithelia. Am J Physiol Renal Physiol. 2012;303(10):F1425-1434. https:\/\/doi.org\/10.1152\/ajprenal.00010.2012.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"613_CR31","doi-asserted-by":"publisher","first-page":"F1622","DOI":"10.1152\/ajprenal.00036.2007","volume":"293","author":"G Elberg","year":"2007","unstructured":"Elberg G, Elberg D, Lewis TV, Guruswamy S, Chen L, Logan CJ, Chan MD, Turman MA. EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells. Am J Physiol Renal Physiol. 2007;293(5):F1622-1632. https:\/\/doi.org\/10.1152\/ajprenal.00036.2007.","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-021-00613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-021-00613-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-021-00613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T11:16:09Z","timestamp":1639048569000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-021-00613-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["613"],"URL":"https:\/\/doi.org\/10.1186\/s40001-021-00613-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"type":"electronic","value":"2047-783X"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"13 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by The First Hospital of Jilin University Committee (approval number: 2019-307).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All study subjects signed written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}